Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Jan 14, 2021 12:20am
162 Views
Post# 32291847

Virus OUT OF CONTROL - Vaccines efficacy is questionnable

Virus OUT OF CONTROL - Vaccines efficacy is questionnable Almost 100,000 people will have died in the last 10 days in the world and the numbers are accelerating.   In US deaths are 4,000 per day, in UK with vaccine deaths are 1,200 per day, in Brazil 1,200 per day, in Mexico 1,400 per day....

Hospitals are overwhelmed and will have to choose who lives and who dies....limited beds available

And outbreaks in Africa with variant virus that evades vaccines makes it redundant.

China has locked down 22 million as a new virus surge is surfacing.

And world governments are so desperate that they are delaying 2nd dose to patients on time, which makes treatment ineffective.   7 people caught covid19 within 28 days of 1st dose. 

The world is in a VERY SAD STATE OF AFFAIRS.

I am afraid that with almost 93 million patients with covid19, this virus is only going to explode much higher and for that much longer.

Spanish flu killed 50 million people and we are close to 2 million as we speak and, virus is just starting to spread as most people did not have virus. 

Spanish flu only stopped when 1/3 of the planet was infected or 500 million.

We are nowhere near this, we have population of close to 8 billion and, 93 million infected.   Even if we tripled this as it might be unreported, we would need 2.5 billion infected to reach similarity with Spanish flu when it finally stopped spreading. 

This virus is going to be with us in 2021, 2022 and 2023.   Maybe in 2024 and 205 we can have some hope of it calming down.    That means TESTING for years and years, and even when virus is calm, we continue TESTING to avoid a resurface as you cannot afford open and lockdown, there will be no companies left.

MPO



<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse